FIELD: medicine.
SUBSTANCE: patient diagnosed with an inflammatory eye disease receives one drop of "Restasis" preparation in the conjunctival sac daily, 2 times a day, for at least 14 days. Additionally, 3-5 U of "Disport" preparation is administered once, departing 4-6 mm downwards from the lower lacrimal eye point.
EFFECT: method allows to interrupt the cascade of inflammatory changes in the eye and prevent local autoimmune response.
2 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING INFLAMMATIONS OF ANTERIOR EYE SEGMENT | 2013 |
|
RU2513597C1 |
| TREATMENT METHOD OF DRY EYE SYNDROME | 2007 |
|
RU2336058C1 |
| METHOD FOR CHOOSING PATHOGENETICALLY CAUSED THERAPEUTIC APPROACH TO VIRAL OCULAR DISEASES | 2012 |
|
RU2494741C1 |
| METHOD FOR TREATMENT OF HEAVY FORMS OF DRY KERATOCONJUNCTIVITIS | 2016 |
|
RU2621553C1 |
| METHOD OF TREATING PERIPHERAL ULCERATIVE KERATITIS ACCOMPANYING SJOGREN'S SYNDROME ASSOCIATED WITH RHEUMATOID ARTHRITIS | 2015 |
|
RU2585611C1 |
| METHOD OF TREATING DRY EYE SYNDROME | 2015 |
|
RU2581495C1 |
| MEANS FOR TREATING THE CASES OF DRY EYE SYNDROME | 2004 |
|
RU2285511C2 |
| METHOD FOR TREATING POSTOPERATIVE UVEITIS CASES | 2006 |
|
RU2307653C1 |
| GEL-LIKE ARTIFICIAL TEARS WITH ANTISEPTIC AND REPARATIVE ACTION | 2018 |
|
RU2679319C1 |
| THERAPY OF CORNEOCONJUNCTIVAL XEROSIS | 2008 |
|
RU2360658C1 |
